| Literature DB >> 34637754 |
Sanxiong Liu1, Kimberly A Aldinger2, Chi Vicky Cheng2, Takae Kiyama3, Mitali Dave2, Hanna K McNamara2, Wukui Zhao4, James M Stafford1, Nicolas Descostes1, Pedro Lee1, Stefano G Caraffi5, Ivan Ivanovski6, Edoardo Errichiello7, Christiane Zweier8, Orsetta Zuffardi9, Michael Schneider10, Antigone S Papavasiliou11, M Scott Perry12, Jennifer Humberson13, Megan T Cho14, Astrid Weber15, Andrew Swale16, Tudor C Badea17, Chai-An Mao3, Livia Garavelli5, William B Dobyns18, Danny Reinberg19.
Abstract
The heterogeneous family of complexes comprising Polycomb repressive complex 1 (PRC1) is instrumental for establishing facultative heterochromatin that is repressive to transcription. However, two PRC1 species, ncPRC1.3 and ncPRC1.5, are known to comprise novel components, AUTS2, P300, and CK2, that convert this repressive function to that of transcription activation. Here, we report that individuals harboring mutations in the HX repeat domain of AUTS2 exhibit defects in AUTS2 and P300 interaction as well as a developmental disorder reflective of Rubinstein-Taybi syndrome, which is mainly associated with a heterozygous pathogenic variant in CREBBP/EP300. Moreover, the absence of AUTS2 or mutation in its HX repeat domain gives rise to misregulation of a subset of developmental genes and curtails motor neuron differentiation of mouse embryonic stem cells. The transcription factor nuclear respiratory factor 1 (NRF1) has a novel and integral role in this neurodevelopmental process, being required for ncPRC1.3 recruitment to chromatin.Entities:
Keywords: AUTS2; NRF1; P300; RSTS; active transcription; brain development; ncPRC1.3; polycomb
Mesh:
Substances:
Year: 2021 PMID: 34637754 PMCID: PMC8604784 DOI: 10.1016/j.molcel.2021.09.020
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970